Atlas Trials

Focused Ultrasound Blood-Brain Barrier Opening in Pontine Diffuse Midline Glioma to Enhance Temozolomide Therapy: Pilot Feasibility Study (FIDES)

Clinical trial NCT07562971 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07562971
Sponsor
UMC Utrecht
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Diffuse Midline Glioma, H3 K27-Altered
Start date
2026-05-01
Primary completion
2030-11-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.